Subsequently, T‐1‐AFPB was semi‐synthesized, and in vitro assays confirmed its potential to inhibit VEGFR‐2 and to inhibit the growth of HepG2 and MCF‐7 cancer cell lines, displaying very high selectivity indices and inducing apoptosis. The gene discussed is KDR; the disease is cancer.